John W Smither Insider Trading $ARQT Arcutis Biotherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John W Smither.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John W Smither. John W Smither is Director in Achaogen Inc ($AKAO) and Chief Financial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in Principia Biopharma Inc. ($PRNB) and Chief Financial Officer in Sienna Biopharmaceuticals, Inc. ($SNNA) and Chief Financial Officer in Arcutis Biotherapeutics, Inc. ($ARQT).
John W Smither in Arcutis Biotherapeutics, Inc.
Trading Symbol: ARQTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John W Smither: Chief Financial Officer
Holdings: 46,821 shares
Latest Transaction: Mar 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John W Smither in Arcutis Biotherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ARQT, KYTH, PRNB, SNNA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 44,982 | |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 1,250 | 41,125 | 86,715 | 88 K to 86.7 K (-1.42 %) |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 500 | 16,450 | 46,321 | 46.8 K to 46.3 K (-1.07 %) |
Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 46,821 | 46.3 K to 46.8 K (+1.08 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 12,396 | 20,833 | 97,684 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 12,396 | 20,833 | 46,321 | 33.9 K to 46.3 K (+36.54 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,500 | 0 | 33,925 | 24.4 K to 33.9 K (+38.89 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 750 | 1,260 | 45,482 | |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 2,000 | 71,280 | 87,965 | 90 K to 88 K (-2.22 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 750 | 26,730 | 25,198 | 25.9 K to 25.2 K (-2.89 %) |
Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 750 | 1,260 | 25,948 | 25.2 K to 25.9 K (+2.98 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,250 | 2,101 | 46,232 | |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 3,750 | 131,250 | 89,965 | 93.7 K to 90 K (-4.00 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 1,250 | 43,750 | 25,198 | 26.4 K to 25.2 K (-4.73 %) |
Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,250 | 2,101 | 26,448 | 25.2 K to 26.4 K (+4.96 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,500 | 2,521 | 47,982 | |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 3,750 | 112,500 | 94,965 | 98.7 K to 95 K (-3.80 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,500 | 45,000 | 25,198 | 26.7 K to 25.2 K (-5.62 %) |
Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,500 | 2,521 | 26,698 | 25.2 K to 26.7 K (+5.95 %) |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 49,482 | |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 98,715 | 100 K to 98.7 K (-1.25 %) |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 23,875 | 24.4 K to 23.9 K (-2.05 %) |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 24,375 | 23.9 K to 24.4 K (+2.09 %) |
Jun 15 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 14,875 | 24,999 | 110,080 | |
Jun 15 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 14,875 | 24,999 | 123,840 | 109 K to 123.8 K (+13.65 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 108,965 | 100 K to 109 K (+9.00 %) |
Page: 1